Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulation

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Chen, Jianzhong ^a   Wang, Jinan ^b   Zhu, Weiliang ^b  

^a SHANDONG JIAOTONG UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID DERIVATIVE; FATTY ACID BINDING PROTEIN 4; FATTY ACID BINDING PROTEIN; PROTEIN BINDING;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HYDROGEN BOND; MATHEMATICAL COMPUTING; MOLECULAR DYNAMICS; MOLECULAR STABILITY; PROTEIN BINDING; PROTEIN STRUCTURE; ADIPOCYTE; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROSIS; DRUG EFFECTS; INFLAMMATION; METABOLIC DISORDER; METABOLISM; PHYSIOLOGY;

ADIPOCYTES; ATHEROSCLEROSIS; FATTY ACID-BINDING PROTEINS; INFLAMMATION; METABOLIC DISEASES; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING;

EID: 84903380098     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099862     Document Type: Article

References (61)

1. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7: 699-705. (Pubitemid 32588026)
2. Banaszak L, Winter N, Xu Z, Bernlohr DA, Cowan S, et al. (1994) Lipid-binding proteins: a family of fatty acid and retinoid transport proteins. Adv Protein Chem 45: 90-152.
3. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, et al. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379. (Pubitemid 26391462)
4. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Med 7: 699-705. (Pubitemid 32588026)
5. Vogel Hertzel A, Bernlohr DA (2000) The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab 11: 175-180. (Pubitemid 30457137)
6. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS (2000) Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141: 3388-3396. (Pubitemid 32269028)
7. Sulsky R, Magnin DR, Huang Y, Simpkins L, Taunk P, et al. (2007) Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorg Med Chem Lett 17: 3511-3515. (Pubitemid 46824179)
8. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, et al. (2002) A central role for JNK in obesity and insulin resistance. Nature 420: 333-336. (Pubitemid 35398190)
9. Scheja L, Makowski L, Uysal KT, Wiesbrock SM, Shimshek DR, et al. (1999) Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes 48: 1987-1994. (Pubitemid 29458361)
10. Melki SA, Abumrad NA (1993) Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation. J Lipid Res 34: 1527-1534. (Pubitemid 23264325)
11. Furuhashi M, Tuncman G, Görgün CZ, Makowski L, Atsumi G, et al. (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447: 959-965. (Pubitemid 46975747)
12. Vural B, Atalar F, Ciftci C, Demirkan A, Susleyici-Duman B, et al. (2008) Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome. Cardiovascular Pathology 17: 392-398.
13. Cabre A, Lazaro I, Girona J, Manzanares J, Marimon F, et al. (2007) Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 195: e150-e158. (Pubitemid 47569987)
14. Ringom R, Axen E, Uppenberg J, Lundbäck T, Rondahl L, et al. (2004) Substituted benzylamino-6-(trifluoromethyl) pyrimidin-4 (1 H) ones: a novel class of selective human A-FABP inhibitors. Bioorg Med Chem Lett 14: 4449-4452. (Pubitemid 39043965)
15. Wallace EM, Lyssikatos J, Blake JF, Seo J, Yang HW, et al. (2006) Potent and selective mitogen-activated protein kinase kinase (MEK) 1, 2 inhibitors. 1. 4-(4-Bromo-2-fluorophenylamino)-1-methylpyridin-2 (1 H)-ones. J Med Chem 49: 441-444. (Pubitemid 43157473)
16. Lehmann F, Haile S, Axen E, Medina C, Uppenberg J, et al. (2004) Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett 14: 4445-4448. (Pubitemid 39043964)
17. Barf T, Lehmann F, Hammer K, Haile S, Axen E, et al. (2009) N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Bioorg Med Chem Lett 19: 1745-1748.
18. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
19. Chen J, Wang J, Xu B, Zhu W, Li G (2011) Insight into Mechanism of Small Molecule Inhibitors of the MDM2-p53 Interaction: Molecular Dynamics Simulation and Free Energy Analysis. J Mol Graph Model 30: 46-53.
20. Hou T, Yu R (2007) Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance. JMed Chem 50: 1177-1188. (Pubitemid 46496318)
21. Xu Y, Wang R (2006) A computational analysis of the binding affinities of FKBP12 inhibitors using the MM PB/SA method. Proteins 64: 1058-1068. (Pubitemid 44420944)
22. Wu EL, Han KL, Zhang JZH (2008) Selectivity of neutral/weakly basic P1 group inhibitors of thrombin and trypsin by a molecular dynamics study. Chemistry - A European Journal 14: 8704-8714.
23. Wang J, Yang H, Zuo Z, Yan X, Wang Y, et al. (2010) Molecular Dynamics Simulations on the Mechanism of Transporting Methylamine and Ammonia by Ammonium Transporter AmtB. J Phys Chem B 114: 15172-15179.
24. Hu G, Wang D, Liu X, Zhang Q (2010) A computational analysis of the binding model of MDM2 with inhibitors. J Comp Aid Mol Des 24: 687-697.
25. Luo Q, Zhang C, Miao L, Zhang D, Bai Y, et al. (2013) Triple mutated antibody scFv2F3 with high GPx activity: insights from MD, docking, MDFE, and MM-PBSA simulation. Amino acids 44: 1009-1019.
26. Verkhivker GM (2012) Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics. PloS one 7: e40897.
27. Chen J, Zhang D, Zhang Y, Li G (2012) Computational studies of difference in binding modes of peptide and non-peptide inhibitors to MDM2/MDMX based on molecular dynamics simulations. IntJ Mol Sci 13: 2176-2195.
28. Chen J, Wang J, Zhu W, Li G (2013) A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings. J Comput Aided Mol Des 27: 965-974.
29. Wang J, Fulford T, Shao Q, Javelle A, Yang H, et al. (2013) Ammonium Transport Proteins with Changes in One of the Conserved Pore Histidines Have Different Performance in Ammonia and Methylamine Conduction. PloS one 8: e62745. doi:62710.61371/journal.pone.0062745.
30. Zhu T, Zhang JZ, He X (2013) Automated Fragmentation QM/MM Calculation of Amide Proton Chemical Shifts in Proteins with Explicit Solvent Model. J Chem Theo Comput 9: 2104-2114.
31. Laberge M, Yonetani T (2008) Molecular dynamics simulations of hemoglobin A in different states and bound to DPG: effector-linked perturbation of tertiary conformations and HbA concerted dynamics. Biophys J 94: 2737-2751.
32. Levy R, Srinivasan A, Olson W, McCammon J (2004) Quasi-harmonic method for studying very low frequency modes in proteins. Biopolymers 23: 1099-1112.
33. Amadei A, Linssen A, Berendsen HJC (2004) Essential dynamics of proteins. Proteins 17: 412-425.
34. Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, et al. (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comp Chem 24: 1999-2012.
35. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25: 1157-1174.
36. Jakalian A, Jack DB, Bayly CI (2002) Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem 23: 1623-1641. (Pubitemid 35330860)
37. Case DA, Darden TA, Cheatham III TE, Simmerling CL, Wang J, et al. (2012) AMBER 12, University of California, San Francisco.
38. Li H, Robertson AD, Jensen JH (2005) Very fast empirical prediction and rationalization of protein pKa values. Proteins 61: 704-721. (Pubitemid 41753142)
39. Bas DC, Rogers DM, Jensen JH (2008) Very fast prediction and rationalization of pKa values for protein-ligand complexes. Proteins 73: 765-783. (Pubitemid 352788657)
40. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-930.
41. Coleman TG, Mesick HC, Darby RL (1977) Numerical integration. Ann Biomed Eng 5: 322-328.
42. Darden T, York D, Pedersen L (1993) Particle mesh Ewald: An N log (N) method for Ewald sums in large systems. J Chem Phys 98: 10089-10092.
43. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, et al. (1995) A smooth particle mesh Ewald method. J Chem Phys 103: 8577-8593.
44. Beveridge DL, DiCapua F (1989) Free energy via molecular simulation: applications to chemical and biomolecular systems. Annu Rev Biophys Biophys Chem 18: 431-492.
45. Kollman P (1993) Free energy calculations: applications to chemical and biochemical phenomena. Chem Rev 93: 2395-2417.
46. Murcko MA (1995) Computational methods to predict binding free energy in ligand-receptor complexes. J Med Chem 38: 4953-4967. (Pubitemid 26012256)
47. Wang J, Morin P, Wang W, Kollman PA (2001) Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J Am Chem Soc 123: 5221-5230. (Pubitemid 32910665)
48. Naïm M, Bhat S, Rankin KN, Dennis S, Chowdhury SF, et al. (2007) Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space. J Chem Inf Model 47: 122-133. (Pubitemid 46225568)
49. Wang Y-T, Su Z-Y, Hsieh C-H, Chen C-L (2009) Predictions of binding for dopamine D2 receptor antagonists by the SIE method. J Chem Inf Model 49: 2369-2375.
50. Cui Q, Sulea T, Schrag JD, Munger C, Hung M-N, et al. (2008) Molecular Dynamics-Solvated Interaction Energy Studies of Protein-Protein Interactions: The MP1-p14 Scaffolding Complex. J Mol Biol 379: 787-802.
51. Purisima EO (1998) Fast summation boundary element method for calculating solvation free energies of macromolecules. J Comput Chem 19: 1494-1504.
52. Purisima EO, Nilar SH (1995) A simple yet accurate boundary element method for continuum dielectric calculations. J Comput Chem 16: 681-689.
53. Bhat S, Purisima EO (2006) Molecular surface generation using a variable-radius solvent probe. Proteins 62: 244-261. (Pubitemid 43063022)
54. Perdih A, Bren U, Solmajer T (2009) Binding free energy calculations of N-sulphonyl-glutamic acid inhibitors of MurD ligase. J Mol Model 15: 983-996.
55. Massova I, Kollman PA (1999) Computational alanine scanning to probe protein-protein interactions: a novel approach to evaluate binding free energies. J Am Chem Soc 121: 8133-8143. (Pubitemid 29444447)
56. Ichiye T, Karplus M (1991) Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations. Proteins 11: 205-217.
57. Ji CG, Zhang JZ (2011) Understanding the molecular mechanism of enzyme dynamics of ribonuclease A through protonation/deprotonation of HIS48. J Am Chem Soc 133: 17727-17737.
58. Huang X, Zheng F, Stokes C, Papke RL, Zhan C-G (2008) Modeling binding modes of α7 nicotinic acetylcholine receptor with ligands: the roles of Gln117 and other residues of the receptor in agonist binding. J Med Chem 51: 6293-6302.
59. Huang X, Zhao X, Zheng F, Zhan C-G (2012) Cocaine Esterase-Cocaine Binding Process and the Free Energy Profiles by Molecular Dynamics and Potential of Mean Force Simulations. J Phys Chem B 116: 3361-3368.
60. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, et al. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19: 1639-1662. (Pubitemid 128590223)
61. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8: 127-134.